Back to Search
SAMY FARAG, MD
MD
Rheumatology Physician
NPI: 1518932474Individual
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
A25821(CA)
Research & Publications (20)
Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma.
PMID 19261329·Leuk Res·2009
3-trial
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia.
PMID 15711571·Bone Marrow Transplant·2005
3-trial
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
PMID 15201999·Int J Oncol·2004
3-trial
Immunotherapeutic strategies of stem cell transplant in lymphoma.
PMID 16163249·Clin Adv Hematol Oncol·2004
8-other
Chronic graft-versus-host disease: where do we go from here?
PMID 14743199·Bone Marrow Transplant·2004
6-review
Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma.
PMID 15464915·Adv Pharmacol·2004
6-review
Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults with low-risk disease.
PMID 12621488·Bone Marrow Transplant·2003
4-observational
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
PMID 12231521·Clin Cancer Res·2002
3-trial
Natural killer cells: biology and application in stem-cell transplantation.
PMID 12473220·Cytotherapy·2002
6-review
New isoflavone glycosides from Iris spuria L. (Calizona) cultivated in Egypt.
PMID 18791667·J Nat Med·2009
8-other
Musculoskeletal affections among kidney recipients: prevalence and risk predictors.
PMID 18443795·Rheumatol Int·2008
8-other
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.
PMID 18541197·Biol Blood Marrow Transplant·2008
3-trial
Antimyeloma effects of a sesquiterpene lactone parthenolide.
PMID 18347184·Clin Cancer Res·2008
8-other
Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma.
PMID 18082257·Leuk Res·2008
3-trial
Fructose-amino acid conjugate and other constituents from Cyperus rotundus L.
PMID 19023813·Nat Prod Res·2008
8-other
Negative selection of hematopoietic progenitor cells by continuous magnetophoresis.
PMID 17379076·Exp Hematol·2007
8-other
A new steroid glycoside and furochromones from Cyperus rotundus L.
PMID 17479423·Nat Prod Res·2007
7-preclinical
A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation.
PMID 17697744·Exp Hematol·2007
8-other
OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
PMID 17699852·Clin Cancer Res·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1300 N VERMONT AVE, #610
LOS ANGELES, CA 90027 - Phone
- (323) 665-5600
Quick Facts
- NPI
- 1518932474
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile